APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceuticals

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Selected research

Industry Growth & Trends

Global Radiopharmaceuticals Industry Growth and Trends Forecast to 2032

2 January 2026117 pages

Choose your research edition.

Industry ResearchRadiopharmaceuticals Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceuticals Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceuticals Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceuticals Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Radiopharmaceuticals market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Radiopharmaceuticals market size, estimates, and forecasts are presented in terms of sales volume (K Dose) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Radiopharmaceuticals market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Radiopharmaceuticals.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Radiopharmaceuticals market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Radiopharmaceuticals Market by Company

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

Radiopharmaceuticals Segment by Type

Diagnostic Radioisotopes

Therapeutic Radioisotopes

Radiopharmaceuticals Segment by Application

Oncology

Cardiology

Other

Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radiopharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Diagnostic Radioisotopes Table 2. Major Company of Therapeutic Radioisotopes Table 3. Global Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 5. Global Radiopharmaceuticals Sales Market Share in Volume by Type (2021-2026) Table 6. Global Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 7. Global Radiopharmaceuticals Sales Market Share in Value by Type (2021-2026) Table 8. Global Radiopharmaceuticals Price by Type (2021-2026) & (US$/Dose) Table 9. Global Radiopharmaceuticals Sales by Type (2027-2032) & (K Dose) Table 10. Global Radiopharmaceuticals Sales Market Share in Volume by Type (2027-2032) Table 11. Global Radiopharmaceuticals Sales by Type (2027-2032) & (US$ Million) Table 12. Global Radiopharmaceuticals Sales Market Share in Value by Type (2027-2032) Table 13. Global Radiopharmaceuticals Price by Type (2027-2032) & (US$/Dose) Table 14. North America Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 15. North America Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 17. Europe Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 19. Asia-Pacific Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 21. Latin America Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 23. Middle East and Africa Radiopharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 24. Radiopharmaceuticals Industry Trends Table 25. Radiopharmaceuticals Industry Drivers Table 26. Radiopharmaceuticals Industry Opportunities and Challenges Table 27. Radiopharmaceuticals Industry Restraints Table 28. Global Radiopharmaceuticals Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Radiopharmaceuticals Revenue Market Share by Company (2021-2026) Table 30. Global Radiopharmaceuticals Sales by Company (2021-2026) & (K Dose) Table 31. Global Radiopharmaceuticals Sales Share by Company (2021-2026) Table 32. Global Radiopharmaceuticals Market Price by Company (2021-2026) & (US$/Dose) Table 33. Global Radiopharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Radiopharmaceuticals Major Company Production Sites and Headquarters Table 35. Global Radiopharmaceuticals Company, Product Type & Application Table 36. Global Radiopharmaceuticals Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Radiopharmaceuticals Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Radiopharmaceuticals Sales by Region (2021-2026) & (K Dose) Table 41. Global Radiopharmaceuticals Sales Market Share in Volume by Region (2021-2026) Table 42. Global Radiopharmaceuticals Sales by Region (2021-2026) & (US$ Million) Table 43. Global Radiopharmaceuticals Sales Market Share in Value by Region (2021-2026) Table 44. Global Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 45. Global Radiopharmaceuticals Sales by Region (2027-2032) & (K Dose) Table 46. Global Radiopharmaceuticals Sales Market Share in Volume by Region (2027-2032) Table 47. Global Radiopharmaceuticals Sales by Region (2027-2032) & (US$ Million) Table 48. Global Radiopharmaceuticals Sales Market Share in Value by Region (2027-2032) Table 49. Global Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2027-2032) Table 50. Global Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 52. Global Radiopharmaceuticals Sales Market Share in Volume by Application (2021-2026) Table 53. Global Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 54. Global Radiopharmaceuticals Sales Market Share in Value by Application (2021-2026) Table 55. Global Radiopharmaceuticals Price by Application (2021-2026) & (US$/Dose) Table 56. Global Radiopharmaceuticals Sales by Application (2027-2032) & (K Dose) Table 57. Global Radiopharmaceuticals Sales Market Share in Volume by Application (2027-2032) Table 58. Global Radiopharmaceuticals Sales by Application (2027-2032) & (US$ Million) Table 59. Global Radiopharmaceuticals Sales Market Share in Value by Application (2027-2032) Table 60. Global Radiopharmaceuticals Price by Application (2027-2032) & (US$/Dose) Table 61. North America Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 62. North America Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 64. Europe Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 66. Asia-Pacific Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 68. Latin America Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 70. Middle East and Africa Radiopharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 71. Bracco Imaging Company Information Table 72. Bracco Imaging Business Overview Table 73. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 74. Bracco Imaging Radiopharmaceuticals Product Portfolio Table 75. Bracco Imaging Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 79. Bayer Radiopharmaceuticals Product Portfolio Table 80. Bayer Recent Development Table 81. Mallinckrodt Company Information Table 82. Mallinckrodt Business Overview Table 83. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 84. Mallinckrodt Radiopharmaceuticals Product Portfolio Table 85. Mallinckrodt Recent Development Table 86. Nordion Company Information Table 87. Nordion Business Overview Table 88. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 89. Nordion Radiopharmaceuticals Product Portfolio Table 90. Nordion Recent Development Table 91. Triad Isotopes Company Information Table 92. Triad Isotopes Business Overview Table 93. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 94. Triad Isotopes Radiopharmaceuticals Product Portfolio Table 95. Triad Isotopes Recent Development Table 96. Lantheus Company Information Table 97. Lantheus Business Overview Table 98. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 99. Lantheus Radiopharmaceuticals Product Portfolio Table 100. Lantheus Recent Development Table 101. IBA Group Company Information Table 102. IBA Group Business Overview Table 103. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 104. IBA Group Radiopharmaceuticals Product Portfolio Table 105. IBA Group Recent Development Table 106. GE Healthcare Company Information Table 107. GE Healthcare Business Overview Table 108. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 109. GE Healthcare Radiopharmaceuticals Product Portfolio Table 110. GE Healthcare Recent Development Table 111. China Isotope & Radiation Company Information Table 112. China Isotope & Radiation Business Overview Table 113. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 114. China Isotope & Radiation Radiopharmaceuticals Product Portfolio Table 115. China Isotope & Radiation Recent Development Table 116. Jubilant Pharma Company Information Table 117. Jubilant Pharma Business Overview Table 118. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 119. Jubilant Pharma Radiopharmaceuticals Product Portfolio Table 120. Jubilant Pharma Recent Development Table 121. Eli Lilly Company Information Table 122. Eli Lilly Business Overview Table 123. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 124. Eli Lilly Radiopharmaceuticals Product Portfolio Table 125. Eli Lilly Recent Development Table 126. Advanced Accelerator Applications Company Information Table 127. Advanced Accelerator Applications Business Overview Table 128. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 129. Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio Table 130. Advanced Accelerator Applications Recent Development Table 131. SIEMENS Company Information Table 132. SIEMENS Business Overview Table 133. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 134. SIEMENS Radiopharmaceuticals Product Portfolio Table 135. SIEMENS Recent Development Table 136. Dongcheng Company Information Table 137. Dongcheng Business Overview Table 138. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 139. Dongcheng Radiopharmaceuticals Product Portfolio Table 140. Dongcheng Recent Development Table 141. Navidea Company Information Table 142. Navidea Business Overview Table 143. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 144. Navidea Radiopharmaceuticals Product Portfolio Table 145. Navidea Recent Development Table 146. North America Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 147. North America Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 148. North America Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 149. North America Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Dose) Table 150. North America Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 151. North America Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Radiopharmaceuticals Market Share by Country (2021-2026) Table 154. North America Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 156. Europe Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 157. Europe Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 158. Europe Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 159. Europe Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Dose) Table 160. Europe Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Radiopharmaceuticals Market Share by Country (2021-2026) Table 164. Europe Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 168. Asia-Pacific Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Dose) Table 170. Asia-Pacific Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Radiopharmaceuticals Market Share by Country (2021-2026) Table 174. Asia-Pacific Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 176. Latin America Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 177. Latin America Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 178. Latin America Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 179. Latin America Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Dose) Table 180. Latin America Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Radiopharmaceuticals Market Share by Country (2021-2026) Table 184. Latin America Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 188. Middle East and Africa Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Radiopharmaceuticals Sales Forecast by Country (2027-2032) & (K Dose) Table 190. Middle East and Africa Radiopharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Radiopharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Radiopharmaceuticals Market Share by Country (2021-2026) Table 194. Middle East and Africa Radiopharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Radiopharmaceuticals Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Radiopharmaceuticals Distributors List Table 199. Radiopharmaceuticals Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Radiopharmaceuticals Image Figure 2. Global Radiopharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceuticals Sales (2021-2032) & (K Dose) Figure 5. Diagnostic Radioisotopes Image Figure 6. Global Diagnostic Radioisotopes Sales YoY Growth (2021-2032) & (K Dose) Figure 7. Therapeutic Radioisotopes Image Figure 8. Global Therapeutic Radioisotopes Sales YoY Growth (2021-2032) & (K Dose) Figure 9. Global Radiopharmaceuticals Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Radiopharmaceuticals Market Share by Type 2025 VS 2032 Figure 11. North America Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 12. North America Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 13. Europe Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 14. Europe Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 17. Latin America Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Radiopharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Radiopharmaceuticals Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Radiopharmaceuticals Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Oncology Image Figure 24. Global Oncology Sales YoY Growth (2021-2032) & (K Dose) Figure 25. Cardiology Image Figure 26. Global Cardiology Sales YoY Growth (2021-2032) & (K Dose) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Dose) Figure 29. Global Radiopharmaceuticals Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Radiopharmaceuticals Market Share by Application 2025 VS 2032 Figure 31. North America Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 32. North America Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 33. Europe Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 34. Europe Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 37. Latin America Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Radiopharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Radiopharmaceuticals Sales Market Share in Value by Application in 2025 Figure 41. North America Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 42. North America Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 46. Europe Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 50. Asia-Pacific Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 54. Latin America Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 58. Middle East and Africa Radiopharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Radiopharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Radiopharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Radiopharmaceuticals Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Radiopharmaceuticals Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Radioisotopes
  • Therapeutic Radioisotopes
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radiopharmaceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Radiopharmaceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Radiopharmaceuticals Market by Type
  6. 1.3.1 Diagnostic Radioisotopes
  7. 1.3.2 Therapeutic Radioisotopes
  8. 1.4 Global Radiopharmaceuticals Market Size by Type
  9. 1.4.1 Global Radiopharmaceuticals Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Radiopharmaceuticals Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Radiopharmaceuticals Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Radiopharmaceuticals Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Radiopharmaceuticals Industry Trends
  2. 2.2 Radiopharmaceuticals Industry Drivers
  3. 2.3 Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceuticals Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Radiopharmaceuticals Revenue (2021-2026)
  2. 3.2 Global Top Players by Radiopharmaceuticals Sales (2021-2026)
  3. 3.3 Global Top Players by Radiopharmaceuticals Price (2021-2026)
  4. 3.4 Global Radiopharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Radiopharmaceuticals Major Company Production Sites & Headquarters
  6. 3.6 Global Radiopharmaceuticals Company, Product Type & Application
  7. 3.7 Global Radiopharmaceuticals Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Radiopharmaceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Radiopharmaceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 Radiopharmaceuticals Regional Status and Outlook
  1. 4.1 Global Radiopharmaceuticals Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Radiopharmaceuticals Historic Market Size by Region
  3. 4.2.1 Global Radiopharmaceuticals Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Radiopharmaceuticals Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Radiopharmaceuticals Forecasted Market Size by Region
  7. 4.3.1 Global Radiopharmaceuticals Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Radiopharmaceuticals Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Radiopharmaceuticals Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Radiopharmaceuticals by Application
  1. 5.1 Radiopharmaceuticals Market by Application
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Other
  5. 5.2 Global Radiopharmaceuticals Market Size by Application
  6. 5.2.1 Global Radiopharmaceuticals Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Radiopharmaceuticals Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Radiopharmaceuticals Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Radiopharmaceuticals Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bracco Imaging
  2. 6.1.1 Bracco Imaging Company Information
  3. 6.1.2 Bracco Imaging Business Overview
  4. 6.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bracco Imaging Radiopharmaceuticals Product Portfolio
  6. 6.1.5 Bracco Imaging Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Radiopharmaceuticals Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Mallinckrodt
  14. 6.3.1 Mallinckrodt Company Information
  15. 6.3.2 Mallinckrodt Business Overview
  16. 6.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mallinckrodt Radiopharmaceuticals Product Portfolio
  18. 6.3.5 Mallinckrodt Recent Developments
  19. 6.4 Nordion
  20. 6.4.1 Nordion Company Information
  21. 6.4.2 Nordion Business Overview
  22. 6.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nordion Radiopharmaceuticals Product Portfolio
  24. 6.4.5 Nordion Recent Developments
  25. 6.5 Triad Isotopes
  26. 6.5.1 Triad Isotopes Company Information
  27. 6.5.2 Triad Isotopes Business Overview
  28. 6.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Triad Isotopes Radiopharmaceuticals Product Portfolio
  30. 6.5.5 Triad Isotopes Recent Developments
  31. 6.6 Lantheus
  32. 6.6.1 Lantheus Company Information
  33. 6.6.2 Lantheus Business Overview
  34. 6.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lantheus Radiopharmaceuticals Product Portfolio
  36. 6.6.5 Lantheus Recent Developments
  37. 6.7 IBA Group
  38. 6.7.1 IBA Group Company Information
  39. 6.7.2 IBA Group Business Overview
  40. 6.7.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 IBA Group Radiopharmaceuticals Product Portfolio
  42. 6.7.5 IBA Group Recent Developments
  43. 6.8 GE Healthcare
  44. 6.8.1 GE Healthcare Company Information
  45. 6.8.2 GE Healthcare Business Overview
  46. 6.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GE Healthcare Radiopharmaceuticals Product Portfolio
  48. 6.8.5 GE Healthcare Recent Developments
  49. 6.9 China Isotope & Radiation
  50. 6.9.1 China Isotope & Radiation Company Information
  51. 6.9.2 China Isotope & Radiation Business Overview
  52. 6.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 China Isotope & Radiation Radiopharmaceuticals Product Portfolio
  54. 6.9.5 China Isotope & Radiation Recent Developments
  55. 6.10 Jubilant Pharma
  56. 6.10.1 Jubilant Pharma Company Information
  57. 6.10.2 Jubilant Pharma Business Overview
  58. 6.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jubilant Pharma Radiopharmaceuticals Product Portfolio
  60. 6.10.5 Jubilant Pharma Recent Developments
  61. 6.11 Eli Lilly
  62. 6.11.1 Eli Lilly Company Information
  63. 6.11.2 Eli Lilly Business Overview
  64. 6.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Eli Lilly Radiopharmaceuticals Product Portfolio
  66. 6.11.5 Eli Lilly Recent Developments
  67. 6.12 Advanced Accelerator Applications
  68. 6.12.1 Advanced Accelerator Applications Company Information
  69. 6.12.2 Advanced Accelerator Applications Business Overview
  70. 6.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio
  72. 6.12.5 Advanced Accelerator Applications Recent Developments
  73. 6.13 SIEMENS
  74. 6.13.1 SIEMENS Company Information
  75. 6.13.2 SIEMENS Business Overview
  76. 6.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 SIEMENS Radiopharmaceuticals Product Portfolio
  78. 6.13.5 SIEMENS Recent Developments
  79. 6.14 Dongcheng
  80. 6.14.1 Dongcheng Company Information
  81. 6.14.2 Dongcheng Business Overview
  82. 6.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Dongcheng Radiopharmaceuticals Product Portfolio
  84. 6.14.5 Dongcheng Recent Developments
  85. 6.15 Navidea
  86. 6.15.1 Navidea Company Information
  87. 6.15.2 Navidea Business Overview
  88. 6.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Navidea Radiopharmaceuticals Product Portfolio
  90. 6.15.5 Navidea Recent Developments
7 North America by Country
  1. 7.1 North America Radiopharmaceuticals Sales by Country
  2. 7.1.1 North America Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Radiopharmaceuticals Sales by Country (2021-2026)
  4. 7.1.3 North America Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 7.2 North America Radiopharmaceuticals Market Size by Country
  6. 7.2.1 North America Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 7.2.3 North America Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Radiopharmaceuticals Sales by Country
  2. 8.1.1 Europe Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Radiopharmaceuticals Sales by Country (2021-2026)
  4. 8.1.3 Europe Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Radiopharmaceuticals Market Size by Country
  6. 8.2.1 Europe Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 8.2.3 Europe Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Radiopharmaceuticals Sales by Country
  2. 9.1.1 Asia-Pacific Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Radiopharmaceuticals Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Radiopharmaceuticals Market Size by Country
  6. 9.2.1 Asia-Pacific Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Radiopharmaceuticals Sales by Country
  2. 10.1.1 South America Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Radiopharmaceuticals Sales by Country (2021-2026)
  4. 10.1.3 South America Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 10.2 South America Radiopharmaceuticals Market Size by Country
  6. 10.2.1 South America Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 10.2.3 South America Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Radiopharmaceuticals Sales by Country
  2. 11.1.1 Middle East and Africa Radiopharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Radiopharmaceuticals Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Radiopharmaceuticals Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Radiopharmaceuticals Market Size by Country
  6. 11.2.1 Middle East and Africa Radiopharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Radiopharmaceuticals Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Radiopharmaceuticals Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Radiopharmaceuticals Value Chain Analysis
  2. 12.1.1 Radiopharmaceuticals Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Radiopharmaceuticals Production Mode & Process
  7. 12.2 Radiopharmaceuticals Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Radiopharmaceuticals Distributors
  10. 12.2.3 Radiopharmaceuticals Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst